CD8A and carcinoma: It is also likely that Entinostat-driven epigenetic modulation may have contributed to a spectrum of effects55,56, as Entinostat has been shown to render carcinoma cells more susceptible to immune killing, including by antigen-specific CD8+ T cells37–39.